标题
Glucagonoma syndrome: a review and update on treatment
作者
关键词
-
出版物
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 30, Issue 12, Pages 2016-2022
出版商
Wiley
发表日期
2016-07-16
DOI
10.1111/jdv.13752
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ectopic Corticotropin-Producing Neuroendocrine Tumor of the Pancreas Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy
- (2016) William Makis et al. CLINICAL NUCLEAR MEDICINE
- Conditional Deletion ofMen1in the Pancreatic β-Cell Leads to Glucagon-Expressing Tumor Development
- (2015) Feng Li et al. ENDOCRINOLOGY
- Glucagonoma syndrome associated with necrolytic migratory erythema
- (2015) Florentino de Araújo Cardoso Filho et al. Revista da Associacao Medica Brasileira
- Recommendations for management of patients with neuroendocrine liver metastases
- (2014) Andrea Frilling et al. LANCET ONCOLOGY
- Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor
- (2014) Sheng-li Wu et al. World Journal of Surgical Oncology
- Meso-pancreatectomy for pancreatic neuroendocrine tumor
- (2014) Alessia Ferrarese et al. International Journal of Surgery
- A Rare but Revealing Sign: Necrolytic Migratory Erythema
- (2013) Nicholas L. Compton et al. AMERICAN JOURNAL OF MEDICINE
- Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
- (2013) George Kanakis et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
- (2013) Hendrik Bergsma et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- The role of nutrition in dermatologic diseases: Facts and controversies
- (2013) Nikita Lakdawala et al. CLINICS IN DERMATOLOGY
- Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma
- (2013) S T Glenn et al. ONCOGENE
- Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections
- (2013) C.- H. Lo et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
- (2012) George A. Poultsides et al. ANNALS OF SURGICAL ONCOLOGY
- Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
- (2012) Geoffrey W. Krampitz et al. ARCHIVES OF SURGERY
- Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances
- (2012) Tetsuhide Ito et al. JOURNAL OF GASTROENTEROLOGY
- Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection
- (2011) Jeffrey A. Norton ARCHIVES OF SURGERY
- Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour
- (2011) Roy Eldor et al. CLINICAL ENDOCRINOLOGY
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas
- (2010) O. Hentic et al. ENDOCRINE-RELATED CANCER
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
- (2010) Aldo Scarpa et al. MODERN PATHOLOGY
- Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease
- (2009) A. Frilling et al. BRITISH JOURNAL OF SURGERY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell Tumor
- (2009) Cuiqi Zhou et al. PANCREAS
- World Health Organization Classification (2004)-based Re-evaluation of 95 nonfunctioning “malignant” pancreatic endocrine tumors reported in Japan
- (2009) Asuka Tsuchiya et al. SURGERY TODAY
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
- (2008) T. R. Halfdanarson et al. ANNALS OF ONCOLOGY
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search